Endometrioid Carcinoma of Female Reproductive System
|
Primary Malignant Neoplasm of Endometrium
|
Malignant Endometrial Neoplasm
|
Carcinoma of the Endometrium
|
Neoplasm of Endometrium
|
Carcinoma Endometrioid
|
Uterine Corpus Cancer
|
Tumor of Endometrium
|
Endometrium Neoplasm
|
Endometrial Cancers
|
Endometrial Ca
|
Endmc
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Endometrial cancer is a malignancy that originates in the endometrium, the mucous lining of the uterus. It is primarily adenocarcinomas, which are cancers that start in cells producing mucus and other fluids. Symptoms include abnormal vaginal bleeding, pain during urination, sexual intercourse, or in the pelvic area. This cancer typically occurs after menopause.
Phenotype Information Associated with the Current Disease:
Categorization: Anatomical classification of the disease manifestations.
HPO Frequency/Orphanet Frequency: Indicates the probability of the manifestation occurring in the current disease, allowing sorting by probability.
HPO Source Accession: Links to HPO for detailed manifestation information.
Data Source: HPO, Orphanet
Gene & Mutation
Genes and Mutations Associated with the Current Disease:
Function: Primary biological roles of the genes.
Score: Indicates the strength of the association between the disease and the gene, with higher scores reflecting stronger associations.
Count: Number of mutations associated with the disease-gene pair. The number in parentheses represents the total data points linked to the same ClinVar ID. Clicking the number reveals mutation details.
Data Source: Clinvar
Related Drugs
Drugs Related to the Current Gene, Displaying CAS Number, Status and Phase.
Data Source: Clinical Trials
Related Mouse Models
Mouse Models Related to the Current Gene. Click on the model name to view detailed information.
Data Source: MGI, Cyagen
References Literature
Most Relevant Literature for the Current Gene, Filterable by Year, Article Type, and Sortable by Impact Factor.